Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Arrowhead Research
ARWR
$12.1B
| $90.1M | 0.04% |
1,436,990
+156,544
| +12% | +$9.91M |
|
302
Hamilton Lane
HLNE
$3.63B
| $90M | 0.04% |
905,660
+103,663
| +13% | +$12.7M |
|
303
Cullen/Frost Bankers
CFR
$10.3B
| $88.7M | 0.04% |
647,235
-317,611
| -33% | -$43.9M |
|
304
Atmus Filtration Technologies
ATMU
$4.37B
| $88.1M | 0.04% |
1,551,117
+181,792
| +13% | +$10.7M |
|
305
Constellation Brands
STZ
$22.2B
| $87.9M | 0.04% |
585,891
+31,749
| +6% | +$4.91M |
|
306
Dell
DELL
$283B
| $86.8M | 0.04% |
528,840
-2,125,222
| -80% | -$283M |
|
307
Carlisle Companies
CSL
$13.6B
| $86M | 0.04% |
257,878
-27,118
| -10% | -$9.87M |
|
308
Roivant Sciences
ROIV
$25.2B
| $85.8M | 0.04% |
3,095,448
+177,339
| +6% | +$4.56M |
|
|
MAZE
309
Maze Therapeutics
MAZE
$1.53B
| $85.3M | 0.04% |
2,858,876
-283,711
| -9% | -$12.5M |
|
310
BioCryst Pharmaceuticals
BCRX
$2.37B
| $84.9M | 0.04% |
8,908,506
+1,504,120
| +20% | +$11.7M |
|
311
Fox Class B
FOX
$20.7B
| $84.8M | 0.04% |
1,597,659
+332,131
| +26% | +$19.2M |
|
312
Spyre Therapeutics
SYRE
$8.87B
| $83.6M | 0.04% |
1,656,164
-172,845
| -9% | -$6.52M |
|
313
Telus
TU
$16B
| $82.9M | 0.04% |
6,470,019
| – | – |
|
|
BNY
314
Bank of New York Mellon
BNY
$108B
| $82.3M | 0.04% |
693,919
-351,156
| -34% | -$41.8M |
|
315
Caterpillar
CAT
$409B
| $81.8M | 0.04% |
115,517
-409
| -0.4% | -$283K |
|
316
Marriott International
MAR
$98.7B
| $81.3M | 0.04% |
248,574
-125,101
| -33% | -$41.1M |
|
317
Advanced Drainage Systems
WMS
$10.9B
| $81.3M | 0.04% |
592,581
-6,229
| -1% | -$964K |
|
318
WEC Energy
WEC
$37.7B
| $81.1M | 0.04% |
700,527
+680,148
| +3,337% | +$76.4M |
|
319
eBay
EBAY
$48.6B
| $79.9M | 0.04% |
877,682
+810,633
| +1,209% | +$72.8M |
|
320
Rhythm Pharmaceuticals
RYTM
$7B
| $79.9M | 0.04% |
918,153
-207,972
| -18% | -$20.2M |
|
321
Halozyme
HALO
$9.72B
| $79.7M | 0.04% |
1,233,658
+369,702
| +43% | +$26.1M |
|
322
Wintrust Financial
WTFC
$10.7B
| $79.3M | 0.04% |
570,819
-38,608
| -6% | -$5.6M |
|
|
ORCL.PRD
323
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $79.1M | 0.04% |
+1,744,850
| New | +$82.5M |
|
324
Roku
ROKU
$21.1B
| $79M | 0.04% |
834,619
+775,861
| +1,320% | +$75.6M |
|
325
Shift4
FOUR
$3.84B
| $78.9M | 0.04% |
1,804,347
+57,900
| +3% | +$3.2M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.